The improvement of FVC at 12 months was modest and did not reach statistical significance because of the small sample size, since only 68% of patients in active treatment and 57% of those who received the placebo completed the trial.
← all excerpts
Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review.
1
—
—